Contractor
ZYDUS PHARMACEUTICALS (USA) INC.
PENNINGTON, NJ
- UEI
- QMFQCPLJ9F36
- Parent UEI
- QMFQCPLJ9F36
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$01
Awards
2
Agencies served
1
Active from Aug 4, 2021 to Sep 9, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36E79724D0021 NEW AWARD FOR DPP-4 SITAGLIPTIN WITH ZYDUS PHARMACEUTICALS (USA)INC. PERIOD OF PERFORMANCE IS 5/18/2024 - 5/17/2025 WITH FOUR ONE-YEAR OPTION PERIODS. | Department of Veterans Affairs | — | Mar 18, 2024 | — |
| 36F79721D0223 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Aug 4, 2021 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier QMFQCPLJ9F36, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Sep 12, 2026.